Lasson U, Mau G, Kübler W, Dörner K
Monatsschr Kinderheilkd. 1982 Jul;130(7):552-5.
In 23 leukemic patients treated according to the West Berlin-protocol, we studied prospectively the plasma levels of the vitamins A (and carotinoids), B1, B2, B6, C, and E, as well as serum zinc values. Blood was drawn on days 0 (before treatment), 15, 29, and 57 of induction therapy. With one exception, plasma vitamin levels did not change significantly during treatment; however, vitamin A increased in the first and decreased in the second phase of induction (p less than 0.01) without clinical signs or symptoms. The serum levels of zinc (p less than 0.05) and the alkaline phosphatase fell continuously from day 0 to 29, but there was no correlation between these two parameters in the same patient. Clinical symptoms of zinc deficiency were not observed. We conclude: 1) That plasma vitamin levels in this limited population are generally unaffected by the underlying malignant disease, the aggressive therapy and altered feeding behaviour, and 2) that the significant decrease of serum zinc does not play a major role in the expression of clinical and biochemical side effects of cytotoxic therapy.
在按照西柏林方案治疗的23例白血病患者中,我们前瞻性地研究了维生素A(及类胡萝卜素)、B1、B2、B6、C和E的血浆水平以及血清锌值。在诱导治疗的第0天(治疗前)、第15天、第29天和第57天采集血液。除1例例外,治疗期间血浆维生素水平无显著变化;然而,诱导治疗的第一阶段维生素A升高,第二阶段降低(p<0.01),且无临床体征或症状。血清锌水平(p<0.05)和碱性磷酸酶从第0天到第29天持续下降,但同一患者的这两个参数之间无相关性。未观察到锌缺乏的临床症状。我们得出结论:1)在这一有限人群中,血浆维生素水平通常不受潜在恶性疾病、积极治疗及喂养行为改变的影响;2)血清锌的显著降低在细胞毒性治疗的临床和生化副作用表达中不起主要作用。